Eureka Therapeutics
生物技术
Eureka Therapeutics 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Eureka Therapeutics 的最新新闻稿
- Eureka Therapeutics Announces UCSF Benioff Children’s Hospitals as First California Site for ARYA-2 Clinical Trial Targeting Pediatric Liver Cancers - Eureka
- Eureka Therapeutics Advances ARYA-3 Clinical Trial to Phase II for Treatment of Liver Cancer Using GPC3-Targeting ARTEMIS® T-cell Therapy - Eureka
- 2022 Press Releases
- 2021 Press Releases
- Eureka Therapeutics Announces Successful Preclinical Results of InvisiMask™ Human Antibody Nasal Spray Against SARS-CoV-2 Infection
- Eureka Therapeutics To Present At Two Upcoming Virtual Conferences
- Eureka In the News | ARTEMIS™ | E-ALPHA® | Eureka Therapeutics
- Eureka Therapeutics To Present At Two Upcoming Virtual Conferences
- Eureka Therapeutics Announces Initiation Of ARYA-1 Clinical Trial To Evaluate Et140203 ARTEMIS® T Cell Therapy In Hepatocellular Carcinoma
- JW Therapeutics Acquires Syracuse Biopharma And License To Eureka Therapeutics’ Solid Tumor Technology In China
- View more press releases Close
通过电子邮件
